Dr Sarah Lord

Senior Research Fellow
Medicine, Sydney Medical School
NHMRC Clinical Trials Centre

Telephone +61 2 9562 5000
Fax +61 2 9565 1863

Map

Selected grants

2014

  • Evaluation of next generation human papillomavirus (HPV) vaccination and associated HPV-based cervical cancer screening strategies in Australia; Canfell K, Castle P, Schiffman M, Nickson C, Caruana M, Simms K, Lord S; National Health and Medical Research Council (NHMRC)/Project Grants.

2010

  • Incidence and prognosis of metastatic breast cancer: A population-based data linkage study; Lord S, Houssami N; National Health and Medical Research Council (NHMRC)/Project Grants.

2009

  • Methods for evaluating the therapeutic impact of diagnosis tests - development of guidelines; Lord S, Chen R; National Health and Medical Research Council (NHMRC)/Project Grants.

2007

  • Methods and appraisal of therapeutic impact studies for new diagnostic tests - development of guidelines; Lord S; University of Sydney/Bridging Support.

2000

  • Provision of assessment and research related services on medical technologies and procedures for the Medical Services Advisory Committee (MSAC); Simes R, Eckermann S, Keech A, Irwig L, Ghersi D, Stockler M, Gebski V, Eckermann S, Lord S, Howard K, Salkeld G; Department of Health and Ageing (Federal)/Research Support.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Keech, A., Gebski, V., Lord, S. (2007). Multiple analyses in clinical trials: sound science or data dredging? In Anthony Keech, Val Gebski, Rhana Pike (Eds.), Interpreting and reporting clinical trials: a guide to the CONSORT statement and the principles of randomised controlled trials, (pp. 123-131). Sydney: AMPCo.

Journals

  • Than, M., Aldous, S., Lord, S., Goodacre, S., Frampton, C., Troughton, R., George, P., Florkowski, C., Ardagh, M., Smyth, D., et al (2014). A 2-Hour Diagnostic Protocol for Possible Cardiac Chest Pain in the Emergency Department: A Randomized Clinical Trial. JAMA Internal Medicine, 174(1), 51-58. [More Information]
  • Barz, T., Staub, L., Melloh, M., Hamann, G., Lord, S., Chatfield, M., Bossuyt, P., Lange, J., Merk, H. (2014). Clinical validity of the nerve root sedimentation sign in patients with suspected lumbar spinal stenosis. The Spine Journal, 14(4), 667-674. [More Information]
  • Horvath, A., Lord, S., StJohn, A., Sandberg, S., Cobbaert, C., Lorenz, S., Monaghan, P., Verhagen-Kamerbeek, W., Ebert, C., Bossuyt, P. (2014). From biomarkers to medical tests: The changing landscape of test evaluation. Clinica Chimica Acta, 427, 49-57. [More Information]
  • Campbell, L., Novak, I., McIntyre, S., Lord, S. (2013). A KT intervention including the evidence alert system to improve clinician's evidence-based practice behavior-a cluster randomized controlled trial. Implementation Science, 8(1), 1-15. [More Information]
  • Lee, C., Simes, R., Brown, C., Gebski, V., Pfisterer, J., Swart, A., Berton-Rigaud, D., Plante, M., Skeie-Jensen, T., Vergote, I., Lord, S., et al (2013). A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer. Annals of Oncology, 24(4), 937-943. [More Information]
  • Melloh, M., Lord, S., Staub, L., Merk, H., Barz, T. (2013). Letters. Spine, 38(11), 968. [More Information]
  • Fox, P., Hudson, M., Brown, C., Lord, S., Gebski, V., de Souza, P., Lee, C. (2013). Markers of systemic inflammation predict survival in patients with advanced renal cell cancer. British Journal of Cancer, 109(1), 147-153. [More Information]
  • Martin, A., Lord, S., Verry, H., Stockler, M., Emery, J. (2013). Risk assessment to guide prostate cancer screening decisions: a cost-effectiveness analysis. Medical Journal of Australia, 198(10), 546-550. [More Information]
  • Walter, S., Macaskill, P., Lord, S., Irwig, L. (2012). Effect of dependent errors in the assessment of diagnostic or screening test accuracy when the reference standard is imperfect. Statistics in Medicine, 31(11-12), 1129-1138. [More Information]
  • Verry, H., Lord, S., Martin, A., Gill, G., Lee, C., Howard, K., Wetzig, N., Simes, R. (2012). Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis. British Journal of Cancer, 106(6), 1045-1052. [More Information]
  • Lew, J., Howard, K., Gertig, D., Smith, M., Clements, M., Nickson, C., Shi, J., Dyer, S., Lord, S., Creighton, P., Canfell, K., et al (2012). Expenditure and resource utilisation for cervical screening in Australia. BMC Health Services Research, 12(1), 1-15. [More Information]
  • Lord, S., Marinovich, M., Patterson, J., Wilcken, N., Kiely, B., Gebski, V., Crossing, S., Roder, D., Gattellari, M., Houssami, N. (2012). Incidence of metastatic breast cancer in an Australian population-based cohort of women with non-metastatic breast cancer at diagnosis. Medical Journal of Australia, 196(11), 688-692. [More Information]
  • Barz, T., Staub, L., Melloh, M., Lord, S. (2012). Letters. Spine, 35(24), E1360. [More Information]
  • Staub, L., Dyer, S., Lord, S., Simes, R. (2012). Linking the evidence: intermediate outcomes in medical test assessments. International Journal of Technology Assessment in Health Care, 28(1), 52-58. [More Information]
  • Staub, L., Lord, S., Simes, R., Dyer, S., Houssami, N., Chen, R., Irwig, L. (2012). Using patient management as a surrogate for patient health outcomes in diagnostic test evaluation. BMC Medical Research Methodology, 12, 1-12. [More Information]
  • Lee, C., Hudson, M., Stockler, M., Coates, A., Ackland, S., Gebski, V., Lord, S., Friedlander, M., Boyle, F., Simes, R. (2011). A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer. Breast Cancer Research and Treatment, 129(2), 467-476. [More Information]
  • Lee, C., Gurney, H., Brown, C., Sorio, R., Donadello, N., Tulunay, G., Meier, W., Bacon, M., Maenpaa, J., Petru, E., Gebski, V., Lord, S., Simes, R., et al (2011). Carboplatin–paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer. British Journal of Cancer, 105(3), 360-365. [More Information]
  • Staub, L., Barz, T., Melloh, M., Lord, S., Chatfield, M., Bossuyt, P. (2011). Clinical validation study to measure the performance of the Nerve Root Sedimentation Sign for the diagnosis of lumbar spinal stenosis. Contemporary Clinical Trials, 32(3), 470-474. [More Information]
  • Lee, C., Friedlander, M., Brown, C., Gebski, V., Georgoulopoulos, A., Vergote, I., Pignata, S., Donadello, N., Schmalfeldt, B., Delva, R., Lord, S., Simes, R., et al (2011). Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer. National Cancer Institute. Journal, 103(17), 1338-1342. [More Information]
  • Lee, C., Simes, R., Brown, C., Lord, S., Wagner, U., Plante, M., Vergote, I., Pisano, C., Parma, G., Burges, A., Gebski, V., et al (2011). Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer. British Journal of Cancer, 105(8), 1144-1150. [More Information]
  • Lord, S., Staub, L., Bossuyt, P., Irwig, L. (2011). Target practice: choosing target conditions for test accuracy studies that are relevant to clinical practice. BMJ: British Medical Journal, 343(7822), d4684-(5pp). [More Information]
  • Griffiths, A., Dyer, S., Lord, S., Pardy, C., Fraser, I., Eckermann, S. (2010). A cost-effectiveness analysis of in-vitro fertilization by maternal age and number of treatment attempts. Human Reproduction, 25(4), 924-931. [More Information]
  • Creighton, P., Lew, J., Clements, M., Smith, M., Howard, K., Dyer, S., Lord, S., Canfell, K. (2010). Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years. BMC Public Health, 10(1), 1-14. [More Information]
  • Botelho, N., Schneiders, F., Lord, S., Freeman, A., Tyagi, S., Nancarrow, D., Hayward, N., Whiteman, D., Lord, R. (2010). Gene expression alterations in formalin-fixed, paraffin-embedded Barrett's esophagus and esophageal adenocarcinoma tissues. Cancer Biology and Therapy, 10(2), 172-179. [More Information]
  • Lee, C., Lord, S., Stockler, M., Coates, A., Gebski, V., Simes, R. (2010). Historical cross-trial comparisons for competing treatments in advanced breast cancer - An empirical analysis of bias. European Journal of Cancer, 46(3), 541-548. [More Information]
  • Barz, T., Melloh, M., Staub, L., Lord, S., Lange, J., Roder, C., Theis, J., Merk, H. (2010). Nerve Root Sedimentation Sign: Evaluation of a New Radiological Sign in Lumbar Spinal Stenosis. Spine, 35(8), 892-897. [More Information]
  • Lee, C., Stockler, M., Coates, A., Gebski, V., Lord, S., Simes, R. (2010). Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer. British Journal of Cancer, 102(9), 1341-1347. [More Information]
  • Houssami, N., Lord, S., Ciatto, S. (2009). Breast cancer screening: emerging role of new imaging techniques as adjuncts to mammography. Medical Journal of Australia, 190(9), 493-498. [More Information]
  • Urwyler, N., Staub, L., Beran, D., Deplazes, M., Lord, S., Alberio, L., Theiler, L., Greif, R. (2009). Is perioperative point-of-care prothrombin time testing accurate compared to the standard laboratory test? Thrombosis and Haemostasis, 102(4), 779-786.
  • Brennan, M., Houssami, N., Lord, S., Macaskill, P., Irwig, L., Dixon, J., Warren, R., Ciatto, S. (2009). Magnetic Resonance Imaging Screening of the Contralateral Breast in Women With Newly Diagnosed Breast Cancer: Systematic Review and Meta-Analysis of Incremental Cancer Detection and Impact on Surgical Management. Journal of Clinical Oncology, 27(33), 5640-5649. [More Information]
  • Lee, C., Lord, S., Coates, A., Simes, R. (2009). Molecular biomarkers to individualise treatment: assessing the evidence. Medical Journal of Australia, 190(11), 631-636. [More Information]
  • Lord, S., Irwig, L., Bossuyt, P. (2009). Using the principles of randomized controlled trial design to guide test evaluation. Medical Decision Making: an international journal, 29(5), E1-E12. [More Information]
  • Houssami, N., Ciatto, S., Macaskill, P., Lord, S., Warren, R., Dixon, J., Irwig, L. (2008). Accuracy and Surgical Impact of Magnetic Resonance Imaging in Breast Cancer Staging: Systematic Review and Meta-Analysis in Detection of Multifocal and Multicentric Cancer. Journal of Clinical Oncology, 26(19), 3248-3258. [More Information]
  • Lord, S., Bernstein, L., Johnson, K., Malone, K., McDonald, J., Marchbanks, P., Simon, M., Strom, B., Press, M., Folger, S., et al (2008). Breast Cancer Risk and Hormone Receptor Status in Older Women by Parity, Age of First birth, and Breastfeeding: a Case-Control Study. Cancer Epidemiology, Biomarkers and Prevention, 17(7), 1723-1730. [More Information]
  • Dyer, S., Levison, D., Chen, R., Lord, S., Blamey, S. (2008). Systematic review of the impact of endoscopic ultrasound on the management of patients with esophageal cancer. International Journal of Technology Assessment in Health Care, 24(1), 25-35. [More Information]
  • Lord, S., Lee, C., Simes, R. (2008). The Role of Predictive and Prognostic Markers in Cancer. Cancer Forum, 32(3), 139-142.
  • Lord, S., Irwig, L., Simes, R. (2007). A philosophical approach to diagnostic test evaluation - In Response. Annals of Internal Medicine, 146(10), 757-758.
  • Lord, S., Lei, W., Craft, P., Cawson, J., Morris, I., Walleser, S., Griffiths, A., Parker, S., Houssami, N. (2007). A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. European Journal of Cancer, 43(13), 1905-1917. [More Information]
  • Griffiths, A., Marinovich, M., Barton, M., Lord, S. (2007). Cost analysis of gamma knife stereotactic radiosurgery. International Journal of Technology Assessment in Health Care, 23(4), 488-494. [More Information]
  • Walleser, S., Griffiths, A., Lord, S., Howard, K., Solomon, M., Gebski, V. (2007). What is the value of computered tomography colonography in patients screening positive for fecal occult blood? A systematic review and economic evaluation. Clinical Gastroenterology and Hepatology, 5(12), 1439-1446. [More Information]
  • Solomon, M., Lord, S., Walleser, S. (2006). Review: computed tomographic colonography is accurate for medium and large colorectal polyps and cancer. Evidence-Based Medicine, 11(5), 153-153. [More Information]
  • Howard, K., Lord, S., Speer, A., Gibson, R., Padbury, R., Kearney, B. (2006). Value of magnetic resonance cholangiopancreatography in the diagnosis of biliary abnormalities in postcholecystectomy patients: a probabilistic cost-effectiveness analysis of diagnostic strategies. International Journal of Technology Assessment in Health Care, 22(1), 109-118. [More Information]
  • Lord, S., Irwig, L., Simes, R. (2006). When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials? Annals of Internal Medicine, 144(11), 850-855. [More Information]
  • Lord, S., Howard, K., Allen, F., Marinovich, M., Burgess, D., King, R., Atherton, J. (2005). A systematic review and economic analysis of drug-eluting coronary stents available in Australia. Medical Journal of Australia, 183(9), 464-71. [More Information]
  • Lord, S., Mack, W., Van Den Berg, D., Pike, M., Ingles, S., Haiman, C., Wang, W., Parisky, Y., Hodis, H., Ursin, G. (2005). Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy. Results from a pilot study. Breast Cancer Research, 7(3), R336-R344. [More Information]
  • Ursin, G., Bernstein, M., Lord, S., Karim, R., Deapen, D., Press, M., Dalinq, J., Norman, S., Liff, J., Marchbanks, P., et al (2005). Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. British Journal of Cancer, 93(3), 364-371. [More Information]
  • Lord, S., Ghersi, D., Gattellari, M., Wilcken, N., Thornton, C., Simes, J. (2004). Antitumour Antibiotic Containing Regimens For Metastatic Breast Cancer. Cochrane Database of Systematic Reviews, 4(CD003367), 1-123.
  • Lord, S., Gebski, V., Keech, A. (2004). Multiple Analyses In Clinical Trials: Sound Science Or Data Dredging? Medical Journal of Australia, 181(8), 452-454.
  • Ursin, G., Bernstein, L., Wang, Y., Lord, S., Deapen, D., Liff, J., Norman, S., Weiss, L., Dalinq, J., Marchbanks, P., et al (2004). Reproductive Factors and Risk of Breast Carcinoma in a Study of White and African-American Women. Cancer, 101(2), 353-362. [More Information]

Report

  • Walleser, S., Griffiths, A., Higgins, A., Lord, S., Howard, K. (2006). Computed Tomography Colonography.
  • Lord, S., Howard, K. (2005). Magnetic resonance cholangiopancreatography (MRCP).
  • Allen, F., Lord, S., Walleser, S., Howard, K., Higgins, A. (2005). SIR-Spheres for the treatment of non-resectable liver tumours.
  • Lord, S., Allen, F., Howard, K. (2004). Drug eluting stents.

2014

  • Than, M., Aldous, S., Lord, S., Goodacre, S., Frampton, C., Troughton, R., George, P., Florkowski, C., Ardagh, M., Smyth, D., et al (2014). A 2-Hour Diagnostic Protocol for Possible Cardiac Chest Pain in the Emergency Department: A Randomized Clinical Trial. JAMA Internal Medicine, 174(1), 51-58. [More Information]
  • Barz, T., Staub, L., Melloh, M., Hamann, G., Lord, S., Chatfield, M., Bossuyt, P., Lange, J., Merk, H. (2014). Clinical validity of the nerve root sedimentation sign in patients with suspected lumbar spinal stenosis. The Spine Journal, 14(4), 667-674. [More Information]
  • Horvath, A., Lord, S., StJohn, A., Sandberg, S., Cobbaert, C., Lorenz, S., Monaghan, P., Verhagen-Kamerbeek, W., Ebert, C., Bossuyt, P. (2014). From biomarkers to medical tests: The changing landscape of test evaluation. Clinica Chimica Acta, 427, 49-57. [More Information]

2013

  • Campbell, L., Novak, I., McIntyre, S., Lord, S. (2013). A KT intervention including the evidence alert system to improve clinician's evidence-based practice behavior-a cluster randomized controlled trial. Implementation Science, 8(1), 1-15. [More Information]
  • Lee, C., Simes, R., Brown, C., Gebski, V., Pfisterer, J., Swart, A., Berton-Rigaud, D., Plante, M., Skeie-Jensen, T., Vergote, I., Lord, S., et al (2013). A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer. Annals of Oncology, 24(4), 937-943. [More Information]
  • Melloh, M., Lord, S., Staub, L., Merk, H., Barz, T. (2013). Letters. Spine, 38(11), 968. [More Information]
  • Fox, P., Hudson, M., Brown, C., Lord, S., Gebski, V., de Souza, P., Lee, C. (2013). Markers of systemic inflammation predict survival in patients with advanced renal cell cancer. British Journal of Cancer, 109(1), 147-153. [More Information]
  • Martin, A., Lord, S., Verry, H., Stockler, M., Emery, J. (2013). Risk assessment to guide prostate cancer screening decisions: a cost-effectiveness analysis. Medical Journal of Australia, 198(10), 546-550. [More Information]

2012

  • Walter, S., Macaskill, P., Lord, S., Irwig, L. (2012). Effect of dependent errors in the assessment of diagnostic or screening test accuracy when the reference standard is imperfect. Statistics in Medicine, 31(11-12), 1129-1138. [More Information]
  • Verry, H., Lord, S., Martin, A., Gill, G., Lee, C., Howard, K., Wetzig, N., Simes, R. (2012). Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis. British Journal of Cancer, 106(6), 1045-1052. [More Information]
  • Lew, J., Howard, K., Gertig, D., Smith, M., Clements, M., Nickson, C., Shi, J., Dyer, S., Lord, S., Creighton, P., Canfell, K., et al (2012). Expenditure and resource utilisation for cervical screening in Australia. BMC Health Services Research, 12(1), 1-15. [More Information]
  • Lord, S., Marinovich, M., Patterson, J., Wilcken, N., Kiely, B., Gebski, V., Crossing, S., Roder, D., Gattellari, M., Houssami, N. (2012). Incidence of metastatic breast cancer in an Australian population-based cohort of women with non-metastatic breast cancer at diagnosis. Medical Journal of Australia, 196(11), 688-692. [More Information]
  • Barz, T., Staub, L., Melloh, M., Lord, S. (2012). Letters. Spine, 35(24), E1360. [More Information]
  • Staub, L., Dyer, S., Lord, S., Simes, R. (2012). Linking the evidence: intermediate outcomes in medical test assessments. International Journal of Technology Assessment in Health Care, 28(1), 52-58. [More Information]
  • Staub, L., Lord, S., Simes, R., Dyer, S., Houssami, N., Chen, R., Irwig, L. (2012). Using patient management as a surrogate for patient health outcomes in diagnostic test evaluation. BMC Medical Research Methodology, 12, 1-12. [More Information]

2011

  • Lee, C., Hudson, M., Stockler, M., Coates, A., Ackland, S., Gebski, V., Lord, S., Friedlander, M., Boyle, F., Simes, R. (2011). A nomogram to predict survival time in women starting first-line chemotherapy for advanced breast cancer. Breast Cancer Research and Treatment, 129(2), 467-476. [More Information]
  • Lee, C., Gurney, H., Brown, C., Sorio, R., Donadello, N., Tulunay, G., Meier, W., Bacon, M., Maenpaa, J., Petru, E., Gebski, V., Lord, S., Simes, R., et al (2011). Carboplatin–paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer. British Journal of Cancer, 105(3), 360-365. [More Information]
  • Staub, L., Barz, T., Melloh, M., Lord, S., Chatfield, M., Bossuyt, P. (2011). Clinical validation study to measure the performance of the Nerve Root Sedimentation Sign for the diagnosis of lumbar spinal stenosis. Contemporary Clinical Trials, 32(3), 470-474. [More Information]
  • Lee, C., Friedlander, M., Brown, C., Gebski, V., Georgoulopoulos, A., Vergote, I., Pignata, S., Donadello, N., Schmalfeldt, B., Delva, R., Lord, S., Simes, R., et al (2011). Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer. National Cancer Institute. Journal, 103(17), 1338-1342. [More Information]
  • Lee, C., Simes, R., Brown, C., Lord, S., Wagner, U., Plante, M., Vergote, I., Pisano, C., Parma, G., Burges, A., Gebski, V., et al (2011). Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer. British Journal of Cancer, 105(8), 1144-1150. [More Information]
  • Lord, S., Staub, L., Bossuyt, P., Irwig, L. (2011). Target practice: choosing target conditions for test accuracy studies that are relevant to clinical practice. BMJ: British Medical Journal, 343(7822), d4684-(5pp). [More Information]

2010

  • Griffiths, A., Dyer, S., Lord, S., Pardy, C., Fraser, I., Eckermann, S. (2010). A cost-effectiveness analysis of in-vitro fertilization by maternal age and number of treatment attempts. Human Reproduction, 25(4), 924-931. [More Information]
  • Creighton, P., Lew, J., Clements, M., Smith, M., Howard, K., Dyer, S., Lord, S., Canfell, K. (2010). Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years. BMC Public Health, 10(1), 1-14. [More Information]
  • Botelho, N., Schneiders, F., Lord, S., Freeman, A., Tyagi, S., Nancarrow, D., Hayward, N., Whiteman, D., Lord, R. (2010). Gene expression alterations in formalin-fixed, paraffin-embedded Barrett's esophagus and esophageal adenocarcinoma tissues. Cancer Biology and Therapy, 10(2), 172-179. [More Information]
  • Lee, C., Lord, S., Stockler, M., Coates, A., Gebski, V., Simes, R. (2010). Historical cross-trial comparisons for competing treatments in advanced breast cancer - An empirical analysis of bias. European Journal of Cancer, 46(3), 541-548. [More Information]
  • Barz, T., Melloh, M., Staub, L., Lord, S., Lange, J., Roder, C., Theis, J., Merk, H. (2010). Nerve Root Sedimentation Sign: Evaluation of a New Radiological Sign in Lumbar Spinal Stenosis. Spine, 35(8), 892-897. [More Information]
  • Lee, C., Stockler, M., Coates, A., Gebski, V., Lord, S., Simes, R. (2010). Self-reported health-related quality of life is an independent predictor of chemotherapy treatment benefit and toxicity in women with advanced breast cancer. British Journal of Cancer, 102(9), 1341-1347. [More Information]

2009

  • Houssami, N., Lord, S., Ciatto, S. (2009). Breast cancer screening: emerging role of new imaging techniques as adjuncts to mammography. Medical Journal of Australia, 190(9), 493-498. [More Information]
  • Urwyler, N., Staub, L., Beran, D., Deplazes, M., Lord, S., Alberio, L., Theiler, L., Greif, R. (2009). Is perioperative point-of-care prothrombin time testing accurate compared to the standard laboratory test? Thrombosis and Haemostasis, 102(4), 779-786.
  • Brennan, M., Houssami, N., Lord, S., Macaskill, P., Irwig, L., Dixon, J., Warren, R., Ciatto, S. (2009). Magnetic Resonance Imaging Screening of the Contralateral Breast in Women With Newly Diagnosed Breast Cancer: Systematic Review and Meta-Analysis of Incremental Cancer Detection and Impact on Surgical Management. Journal of Clinical Oncology, 27(33), 5640-5649. [More Information]
  • Lee, C., Lord, S., Coates, A., Simes, R. (2009). Molecular biomarkers to individualise treatment: assessing the evidence. Medical Journal of Australia, 190(11), 631-636. [More Information]
  • Lord, S., Irwig, L., Bossuyt, P. (2009). Using the principles of randomized controlled trial design to guide test evaluation. Medical Decision Making: an international journal, 29(5), E1-E12. [More Information]

2008

  • Houssami, N., Ciatto, S., Macaskill, P., Lord, S., Warren, R., Dixon, J., Irwig, L. (2008). Accuracy and Surgical Impact of Magnetic Resonance Imaging in Breast Cancer Staging: Systematic Review and Meta-Analysis in Detection of Multifocal and Multicentric Cancer. Journal of Clinical Oncology, 26(19), 3248-3258. [More Information]
  • Lord, S., Bernstein, L., Johnson, K., Malone, K., McDonald, J., Marchbanks, P., Simon, M., Strom, B., Press, M., Folger, S., et al (2008). Breast Cancer Risk and Hormone Receptor Status in Older Women by Parity, Age of First birth, and Breastfeeding: a Case-Control Study. Cancer Epidemiology, Biomarkers and Prevention, 17(7), 1723-1730. [More Information]
  • Dyer, S., Levison, D., Chen, R., Lord, S., Blamey, S. (2008). Systematic review of the impact of endoscopic ultrasound on the management of patients with esophageal cancer. International Journal of Technology Assessment in Health Care, 24(1), 25-35. [More Information]
  • Lord, S., Lee, C., Simes, R. (2008). The Role of Predictive and Prognostic Markers in Cancer. Cancer Forum, 32(3), 139-142.

2007

  • Lord, S., Irwig, L., Simes, R. (2007). A philosophical approach to diagnostic test evaluation - In Response. Annals of Internal Medicine, 146(10), 757-758.
  • Lord, S., Lei, W., Craft, P., Cawson, J., Morris, I., Walleser, S., Griffiths, A., Parker, S., Houssami, N. (2007). A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. European Journal of Cancer, 43(13), 1905-1917. [More Information]
  • Griffiths, A., Marinovich, M., Barton, M., Lord, S. (2007). Cost analysis of gamma knife stereotactic radiosurgery. International Journal of Technology Assessment in Health Care, 23(4), 488-494. [More Information]
  • Keech, A., Gebski, V., Lord, S. (2007). Multiple analyses in clinical trials: sound science or data dredging? In Anthony Keech, Val Gebski, Rhana Pike (Eds.), Interpreting and reporting clinical trials: a guide to the CONSORT statement and the principles of randomised controlled trials, (pp. 123-131). Sydney: AMPCo.
  • Walleser, S., Griffiths, A., Lord, S., Howard, K., Solomon, M., Gebski, V. (2007). What is the value of computered tomography colonography in patients screening positive for fecal occult blood? A systematic review and economic evaluation. Clinical Gastroenterology and Hepatology, 5(12), 1439-1446. [More Information]

2006

  • Walleser, S., Griffiths, A., Higgins, A., Lord, S., Howard, K. (2006). Computed Tomography Colonography.
  • Solomon, M., Lord, S., Walleser, S. (2006). Review: computed tomographic colonography is accurate for medium and large colorectal polyps and cancer. Evidence-Based Medicine, 11(5), 153-153. [More Information]
  • Howard, K., Lord, S., Speer, A., Gibson, R., Padbury, R., Kearney, B. (2006). Value of magnetic resonance cholangiopancreatography in the diagnosis of biliary abnormalities in postcholecystectomy patients: a probabilistic cost-effectiveness analysis of diagnostic strategies. International Journal of Technology Assessment in Health Care, 22(1), 109-118. [More Information]
  • Lord, S., Irwig, L., Simes, R. (2006). When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials? Annals of Internal Medicine, 144(11), 850-855. [More Information]

2005

  • Lord, S., Howard, K., Allen, F., Marinovich, M., Burgess, D., King, R., Atherton, J. (2005). A systematic review and economic analysis of drug-eluting coronary stents available in Australia. Medical Journal of Australia, 183(9), 464-71. [More Information]
  • Lord, S., Howard, K. (2005). Magnetic resonance cholangiopancreatography (MRCP).
  • Lord, S., Mack, W., Van Den Berg, D., Pike, M., Ingles, S., Haiman, C., Wang, W., Parisky, Y., Hodis, H., Ursin, G. (2005). Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy. Results from a pilot study. Breast Cancer Research, 7(3), R336-R344. [More Information]
  • Ursin, G., Bernstein, M., Lord, S., Karim, R., Deapen, D., Press, M., Dalinq, J., Norman, S., Liff, J., Marchbanks, P., et al (2005). Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. British Journal of Cancer, 93(3), 364-371. [More Information]
  • Allen, F., Lord, S., Walleser, S., Howard, K., Higgins, A. (2005). SIR-Spheres for the treatment of non-resectable liver tumours.

2004

  • Lord, S., Ghersi, D., Gattellari, M., Wilcken, N., Thornton, C., Simes, J. (2004). Antitumour Antibiotic Containing Regimens For Metastatic Breast Cancer. Cochrane Database of Systematic Reviews, 4(CD003367), 1-123.
  • Lord, S., Allen, F., Howard, K. (2004). Drug eluting stents.
  • Lord, S., Gebski, V., Keech, A. (2004). Multiple Analyses In Clinical Trials: Sound Science Or Data Dredging? Medical Journal of Australia, 181(8), 452-454.
  • Ursin, G., Bernstein, L., Wang, Y., Lord, S., Deapen, D., Liff, J., Norman, S., Weiss, L., Dalinq, J., Marchbanks, P., et al (2004). Reproductive Factors and Risk of Breast Carcinoma in a Study of White and African-American Women. Cancer, 101(2), 353-362. [More Information]

To update your profile click here. For support on your academic profile contact .